Cutler Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-17,800
| Closed | -$330K | – | 2145 |
|
|
2023
Q3 | $330K | Sell |
17,800
-100
| -0.6% | -$1.85K | 0.03% | 310 |
|
|
2023
Q2 | $197K | Hold |
17,900
| – | – | 0.03% | 340 |
|
|
2023
Q1 | $240K | Sell |
17,900
-85
| -0.5% | -$1.14K | 0.02% | 323 |
|
|
2022
Q4 | $222K | Sell |
17,985
-2,211
| -11% | -$27.3K | 0.02% | 422 |
|
|
2022
Q3 | $281K | Buy |
20,196
+6,111
| +43% | +$85K | 0.02% | 402 |
|
|
2022
Q2 | $194K | Sell |
14,085
-4,371
| -24% | -$60.2K | 0.01% | 477 |
|
|
2022
Q1 | $300K | Buy |
18,456
+10,256
| +125% | +$167K | 0.02% | 480 |
|
|
2021
Q4 | $133K | Sell |
8,200
-1,100
| -12% | -$17.8K | 0.01% | 831 |
|
|
2021
Q3 | $138K | Sell |
9,300
-100
| -1% | -$1.48K | 0.01% | 830 |
|
|
2021
Q2 | $187K | Sell |
9,400
-400
| -4% | -$7.96K | 0.01% | 757 |
|
|
2021
Q1 | $226K | Buy |
9,800
+7,700
| +367% | +$178K | 0.01% | 627 |
|
|
2020
Q4 | $51K | Sell |
2,100
-3,400
| -62% | -$82.6K | ﹤0.01% | 1005 |
|
|
2020
Q3 | $228K | Buy |
+5,500
| New | +$228K | 0.01% | 454 |
|
|
2020
Q2 | – | Sell |
-2,400
| Closed | -$151K | – | 2252 |
|
|
2020
Q1 | $151K | Buy |
2,400
+800
| +50% | +$50.3K | 0.01% | 506 |
|
|
2019
Q4 | $198K | Buy |
1,600
+1,260
| +371% | +$156K | 0.01% | 517 |
|
|
2019
Q3 | $22K | Sell |
340
-460
| -58% | -$29.8K | ﹤0.01% | 1037 |
|
|
2019
Q2 | $63K | Buy |
800
+600
| +300% | +$47.3K | 0.01% | 837 |
|
|
2019
Q1 | $22K | Sell |
200
-1,250
| -86% | -$138K | ﹤0.01% | 1040 |
|
|
2018
Q4 | $146K | Buy |
+1,450
| New | +$146K | 0.01% | 482 |
|
|
2018
Q3 | – | Sell |
-1,990
| Closed | -$166K | – | 2312 |
|
|
2018
Q2 | $166K | Buy |
1,990
+1,190
| +149% | +$99.3K | 0.01% | 554 |
|
|
2018
Q1 | $49K | Buy |
800
+600
| +300% | +$36.8K | ﹤0.01% | 953 |
|
|
2017
Q4 | $11K | Sell |
200
-2,245
| -92% | -$123K | ﹤0.01% | 1589 |
|
|
2017
Q3 | $141K | Sell |
2,445
-3,756
| -61% | -$217K | 0.01% | 868 |
|
|
2017
Q2 | $750K | Sell |
6,201
-75
| -1% | -$9.07K | 0.03% | 374 |
|
|
2017
Q1 | $709K | Sell |
6,276
-16,625
| -73% | -$1.88M | 0.03% | 379 |
|
|
2016
Q4 | $2.49M | Buy |
22,901
+8,535
| +59% | +$927K | 0.09% | 127 |
|
|
2016
Q3 | $2.36M | Buy |
14,366
+10,116
| +238% | +$1.66M | 0.11% | 101 |
|
|
2016
Q2 | $606K | Sell |
4,250
-653
| -13% | -$93.1K | 0.03% | 321 |
|
|
2016
Q1 | $629K | Buy |
4,903
+253
| +5% | +$32.5K | 0.04% | 268 |
|
|
2015
Q4 | $694K | Buy |
+4,650
| New | +$694K | 0.04% | 300 |
|